Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses

리툭시맙으로 치료받은 자가면역 질환 환자와 2회 접종에 무반응자에서 세 번째 COVID-19 백신 접종 후 체액 반응 비율이 매우 낮음

Published on
Journal: RMD Open
[저자] Samuel Bitoun, Jérôme Avouac, Julien Henry, Roba Ghossan, Omar Al Tabaa, Rakiba Belkhir, Gaetane Nocturne, Alice Andrée Mariaggi, Flore Rozenberg, Christelle Vauloup-Fellous, Xavier Mariette, Raphaèle Seror
[Category] COVID19(2023년), MERS, SARS, 진단,
PMC URL    [DOI] 10.1136/rmdopen-2022-002308    
[Article Type] Article
[Source] PMC

No abstract available
Keywords: Arthritis, Rheumatoid; Autoimmune Diseases; COVID-19; Rituximab; Vaccination.

All Keywords
【저자키워드】 COVID-19, vaccination, rituximab, Autoimmune diseases, Arthritis, Rheumatoid, 【초록키워드】 Abstract, 【제목키워드】 COVID-19 vaccine, Autoimmune disease, Patient, dose, humoral, non-responder, treated,
사용 가능한 초록 없음 {{ 키워드: }} 관절염, 류마티스; 자가면역질환; 코로나바이러스감염증-19 : 코로나19; 리툭시맙; 백신 접종.